Published in Health Business Week, May 22nd, 2009
6.6% to $452 per day, an increase of $28 per patient day, as the
company's overall patient base continued shifting to a higher acuity
mix; -- Consolidated EBITDAR improved 22.4% to $21.1 million in the quarter,
and EBITDAR margins improved by 105 basis points to 16.2%; and -- Consolidated net income climbed 25.1% to $7.9 million, compared to
Keywords: The Ensign Group, Inc.
This article...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-05-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.